Cell line provisioning
Preparation and standardisation of clonal lines, versioned and ready to deploy.
CellOps provides lifecycle management for mammalian cell systems, from genetic payload deployment to scalable bioprocess operations.
| NAME | CLONES | PASSAGE | DENSITY | VIABILITY | STATE |
|---|
Standardised, observable and repeatable. We run the operational layer so your process behaves the same on Monday as it did on Friday.
Preparation and standardisation of clonal lines, versioned and ready to deploy.
Controlled delivery of genetic constructs with a defined rollout and a defined rollback.
Start-up, feeding and day-to-day care of running cultures, on call.
Scheduling and coordination of culture systems across vessels and sites.
Continuous monitoring of cell health, density and process drift, with alerting.
Scale-up that preserves process identity, with cryopreserved backups of every clone.
The mapping is not literal, and it is not meant to be. It is a shared way of thinking about state, lifecycle and failure.
| Platform engineering | Upstream bioprocess |
|---|---|
| Container | Mammalian cell |
| Container image | Stable cell clone |
| Deployment | Transfection / culture launch |
| Runtime | Cultivation |
| Orchestrator | Bioreactor / culture system |
| Replica | Clonal population |
| Health check | Viability assessment |
| Backup | Cryopreservation |
| Incident response | Contamination and deviation response |
| Resource provisioning | Medium supply |
They have state, resources, dependencies, a lifecycle and criteria for being healthy. We manage them accordingly.
A repeatable result is a property of a well-run system, not a lucky outcome of one good experiment.
The rigour DevOps brought to software delivery applies just as well to cell culture.
A working cell line is the start. Stable operation, control, scale and recovery are the job.
Service levels for managed culture operations on the CellOps platform.
Field reports and research from the people who run the cultures.
How we split a running culture into new vessels without interrupting the process, and what we monitor while it happens.
9 min readWhy every culture vessel is replaceable, labelled and rebuilt from a known clone rather than nursed back to health.
7 min readFifth annual industry survey: how teams monitor viability, handle contamination and measure reproducibility.
14 min readTell us about your cell line, your payload and your target scale. We will reply with an onboarding plan.
Request platform access